Mouth-washings with recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) do not improve grade III-IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a randomized double-blind placebo-controlled study

Bone Marrow Transplantation

Volumn 29, Issue 9, 2002, Pages 783-787

  Valcarcel D ^a   Sanz, M A ^a   Sureda, A ^a   Sala, M ^a   Munoz L ^a   Subira M ^a   Laborda, R ^a   Clopes A ^a   Sierra, J ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Granulocyte macrophage colony stimulating factor; Oropharyngeal mucositis; Stem cell transplantation

Indexed keywords

ACICLOVIR; ANALGESIC AGENT; BUSULFAN; CARMUSTINE; CEFEPIME; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; IMIPENEM; MELPHALAN; METHOTREXATE; MOLGRAMOSTIN; NORFLOXACIN; PLACEBO; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SODIUM CHLORIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DYSPHAGIA; FEMALE; FEVER; FOOD INTAKE; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; MALE; MALIGNANT NEOPLASTIC DISEASE; MOUTH HYGIENE; MOUTH INFECTION; MUCOSA INFLAMMATION; MYCOSIS; NEUTROPENIA; OROPHARYNX; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SLEEP; TREATMENT FAILURE; TREATMENT OUTCOME; VIRUS INFECTION;

ADOLESCENT; ADULT; DOUBLE-BLIND METHOD; FEMALE; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTHWASHES; NEUTROPENIA; OROPHARYNX; PLACEBOS; PROSPECTIVE STUDIES; STOMATITIS; TREATMENT OUTCOME;

EID: 85047699364     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703543     Document Type: Article

References (16)

1. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haematopoietic progenitor rescue
2. Mucositis: Its occurrence, consequences, and treatment in the oncology setting
3. Prevention and treatment of oral mucositis following cancer chemotherapy
4. Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis - Are there new strategies?
5. Studies of oral neutrophil levels in patients receiving G-CSF after autologous marrow transplantation
6. Effect of granulocyte colony-stimulating factor on chemotherapy-induced oral mucositis
7. Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma
8. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lung cancer
9. A phase III randomised, double-blind placebo-control trial of rhGM-CSF following allogeneic bone marrow transplantation
10. RhGM-CSF vs placebo following rhGM-CSF mobilised PBPC transplantation: A phase III double-blind randomised trial
11. Effect of topical oral G-CSF on oral mucositis: A randomised placebo-controlled trial
12. Effect of locally applied GM-CSF on oral mucositis after stem cell transplantation: A prospective placebo-controlled double-blind study
13. Reporting results in cancer patients
14. Effect of granulocyte-macrophage colony-stimulating factor on prevention of mucositis in head and neck cancer patients treated with chemoradiotherapy
15. A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy: A preliminary report
16. Evaluation of GM-CSF mouthwash for prevention of chemotherapy induced mucositis: A randomized double-blind dose-ranging study